Position in TGTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$145,601,548
+$38,934,454 QoQ
Shares Held
2,650,192
-17.5% QoQ
Ownership
1.73%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#9
of 423 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Clearbridge Investments, LLC holds $2,924,434,154 across 28 Biotechnology names. TGTX ranks #4 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,342,915 | $1,163,796,167 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,259,483 | $379,142,167 | |
| 3 | ARGX |
Argenx SE
|
253,776 | $235,445,759 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
This page
|
2,650,192 | $145,601,548 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
725,335 | $88,911,564 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
696,473 | $77,329,397 | |
| 7 | INSM |
INSMED Inc
|
715,922 | $76,331,603 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
639,734 | $74,893,659 |
All Filings in TGTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,601,548 | 2,650,192 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $106,667,094 | 3,210,930 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $102,785,863 | 3,448,033 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $167,781,659 | 4,644,475 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $109,861,490 | 3,052,556 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $104,270,939 | 2,644,457 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $55,237,322 | 1,835,127 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||